Assessing the Direct Costs of Treating Nonvalvular Atrial Fibrillation in the United States
Top Cited Papers
- 1 September 2006
- journal article
- Published by Elsevier in Value in Health
- Vol. 9 (5) , 348-356
- https://doi.org/10.1111/j.1524-4733.2006.00124.x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Prevalence of Diagnosed Atrial Fibrillation in AdultsJAMA, 2001
- Second Line Pharmacological Management of Paroxysmal and Persistent Atrial Fibrillation in France: A Cost AnalysisValue in Health, 2000
- Making Decisions About Antithrombotic Therapy in Heart Disease: Decision Analytic and Costeffectiveness IssuesChest, 1998
- Cost-effectiveness of anticoagulation in nonrheumatic atrial fibrillation in the primary prevention of ischemic stroke.Stroke, 1998
- Cost-Effectiveness of Preference-Based Antithrombotic Therapy for Patients With Nonvalvular Atrial FibrillationStroke, 1998
- Cost Comparison of Radiofrequency Modification and Ablation of the Atrioventricular Junction in Patients With Chronic Atrial FibrillationCirculation, 1997
- Prevalence, Age Distribution, and Gender of Patients With Atrial FibrillationArchives of internal medicine (1960), 1995
- Cost-effectiveness analysis in heart disease, part III: Ischemia, congestive heart failure, and arrhythmiasProgress in Cardiovascular Diseases, 1995
- Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective.BMJ, 1992
- Reduction in medical care cost associated with radiofrequency catheter ablation of accessory pathwaysThe American Journal of Cardiology, 1991